Riskpilot← Back to searchSign inGet full accessHolmström Urokonsult AB
ABIn liquidationOrg 5591575377Tertiary education · NACE 8542Est. 20180 employees
Revenue 2021
SEK 15K
-65% vs 2020
EBITDA margin
-100.0%
-267% vs 2020
Equity ratio
71.7%
Financial strength
Net profit 2021
SEK -15K
-314% vs 2020
| Revenue | SEK 15K | -65% |
| EBITDA | SEK -15K | -267% |
| Net profit | SEK -15K | -314% |
| Total assets | SEK 60K | -32% |
| Equity | SEK 43K | -25% |
| Employees | 0 | — |
Legal name
Holmström Urokonsult AB
Org number
5591575377
Legal form
Aktiebolag
NACE code
8542 · Tertiary education
Founded
30 april 2018
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-08-31
Financial year
January – December
Company purpose
Bolaget skall bedriva läkarvård samt konsult- och utbildningsverk samhet inom området, medicinsk och farmaceutisk forskning och utveckling, litterär verksamhet och handel med värdepapper ävensom idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 182 | 43 | 15 |
| Staff expenses | — | — | — |
| EBITDA | 154 | 9 | −15 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 154 | 9 | −15 |
| Net financials | — | — | — |
| Profit before tax | 154 | 9 | −15 |
| Tax | −35 | −2 | −0 |
| Net profit | 119 | 7 | −15 |
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Total assets | 198 | 88 | 60 |
| Equity | 169 | 57 | 43 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 29 | 31 | 17 |
| Total debt | 29 | 31 | 17 |
EBITDA margin
-100.0%
This company
15.8%
Market median
-733% vs market
20192021
Equity ratio
71.7%
This company
38.2%
Market median
+88% vs market
20192021
Return on equity
-34.9%
This company
18.4%
Market median
-290% vs market
20192021
Net profit margin
-100.0%
This company
8.1%
Market median
-1335% vs market
20192021
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20192021
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20192021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-04-01 – 2019-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EH Liquidator | Liquidator | 2020 |
| Former (1) | ||
AK Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Holmström Urokonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ewa Helena Holmquist | Liquidator | 0 companies |
| Anna Kristina Holmström | Authorized Recipient of Service | 0 companies |
| Benny Kaj Holmström | Board of Directors | 0 companies |
| Jonny Jarl Henry Holmström | Deputy Board Member | 0 companies |